Core Laboratories (CLB) Misses Q3 EPS by 4c, Guidance Comes in Light
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.64 -1.1%
EPS Growth %: +36.4%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +36.4%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.35, $0.04 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $143.5 million versus the consensus estimate of $146.23 million.
GUIDANCE:
Core Laboratories sees Q4 2016 EPS of $0.38-$0.40, versus the consensus of $0.41. Core Laboratories sees Q4 2016 revenue of $143-145 million, versus the consensus of $148.2 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Nike names former Pfizer CFO David Denton as new finance chief
- After-Hours Stock Movers: FDX, CBRS, NKE
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
